Ken Griffin Coh Bar, Inc. Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.17 - $0.34 $1,930 - $3,861	-11,357 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.25 - $0.43 $19,467 - $33,484	-77,870 Reduced 87.27%	11,357 $4,000
Q3 2021 Nov 15, 2021	BUY	$0.96 - $1.62 $85,657 - $144,547	89,227 New	89,227 $86,000
Q1 2021 May 17, 2021	SELL	$1.26 - $2.02 $29,835 - $47,831	-23,679 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$0.9 - $1.54 $21,311 - $36,465	23,679 New	23,679 $32,000
Q2 2020 Aug 14, 2020	SELL	$1.08 - $4.0 $20,026 - $74,172	-18,543 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$1.01 - $2.74 $18,728 - $50,807	18,543 New	18,543 $21,000
Q4 2019 Feb 14, 2020	SELL	$1.2 - $2.34 $26,150 - $50,993	-21,792 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$1.3 - $1.76 $28,329 - $38,353	21,792 New	21,792 $28,000

1.14K

Ticker CWBR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,906,940
Market Cap $1.45M
Description
CohBar, Inc., a clinical stage biotechnology company, focuses in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The company develops MBTs to treat non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis, type 2 diabetes, acute...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.